Clinical Trials Directory

Trials / Conditions / Nausea and Vomiting, Chemotherapy-Induced

Nausea and Vomiting, Chemotherapy-Induced

19 registered clinical trials studyying Nausea and Vomiting, Chemotherapy-Induced — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingMedical Cannabis for Nausea in Patients Receiving Moderately or Highly Emetogenic Chemotherapy
NCT07374939
University of RochesterPhase 2
RecruitingStudy With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting
NCT06904235
Helsinn Healthcare SAPhase 2
Not Yet RecruitingEvaluating the Efficacy and Safety of HSK21542 Injection in Chemotherapy-induced Nausea and Vomiting
NCT06593782
First Affiliated Hospital of Wenzhou Medical UniversityPhase 2
Active Not RecruitingThe Effect of Relaxation Breathing Exercise on Chemotherapy Induced Nausea and Vomiting
NCT07456982
Marmara UniversityN/A
CompletedThe Effect of Using Interactive Mobile Application for the Management of Chemotherapy- Induced Nausea and Vomi
NCT04693832
Trakya UniversityN/A
CompletedMeditation for Chemotherapy-Induced Nausea and Vomiting in Women With Breast Cancer
NCT07470619
Near East University, TurkeyN/A
CompletedTo Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxiflox
NCT01449188
GlaxoSmithKlinePhase 1
CompletedA Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
NCT00601172
GlaxoSmithKlinePhase 3
CompletedThe Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in S
NCT00511823
GlaxoSmithKlinePhase 1
CompletedThe Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
NCT00440128
GlaxoSmithKlinePhase 1
CompletedA Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults
NCT00460707
GlaxoSmithKlinePhase 1
CompletedA Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Health
NCT00437229
GlaxoSmithKlinePhase 1
CompletedA Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769
NCT00405080
GlaxoSmithKlinePhase 1
CompletedA Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemot
NCT00431236
GlaxoSmithKlinePhase 3
CompletedA Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Voluntee
NCT00404274
GlaxoSmithKlinePhase 1
CompletedStudy Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [
NCT00404378
GlaxoSmithKlinePhase 1
CompletedIntravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
NCT00366834
GlaxoSmithKlinePhase 3
TerminatedCyclophosphamide Drug Interaction Study In Cancer Patients
NCT00334646
GlaxoSmithKlinePhase 1
CompletedStudy Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
NCT00104403
GlaxoSmithKlinePhase 2